LETTER TO DAVID PICKENS FROM JOHN C. LAWN

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP90M00551R001600840026-4
• Release Decision: RIPPUB
• Original Classification: K
• Document Page Count: 4
• Document Creation Date: December 23, 2016
• Document Release Date: November 9, 2012
• Sequence Number: 26
• Publication Date: April 28, 1988
• Content Type: LETTER

STAT
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09:
CIA-RDP90M00551R001600840026-4
STAT
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09:
CIA-RDP90M00551R001600840026-4
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4
NATIONAL DRUG POLICY BOARD 1E'3
Wahington, D.C. 20530
APR 2 8 1988
Mr. David Pickens
Executive Director
National Drug Policy Board
9th & Pennsylvania Ave., N.W.
Washington, D.C. 20530
Dear Mr. Pickens:
As requested in your April 4 memorandum, enclosed are
comments on the first draft of the 1987 Progress Report.
Annotations have been made directly on Chapters IT and VII
of the draft report. Additional material has been received
from INTERPOL for Chapter VII. In addition, I strongly
recommend that Chapter I be discarded in favor of either an
executive summary or a lead-in with Chapter II.
Should you have any questions regarding the report, please
contact Mr. Thomas Byrne, NDIC Working Group Chairman, on
633-1071, for further information.
Enclosure
cc: NDIC Members
Tom Byrne/OI
Sincerely,
//
(K-
hn C. Lawn, Chairman
National Drug Intelligence
Committee
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4
NATIONAL DRUG POLICY BOARD
Washington, D.C. 20530
MAY 4 1988
Honorable Francis A. Keating II
Assistant Secretary (Enforcement)
Department of the Treasury
15th & Pennsylvania Avenue, N.W.
Washington, D.C. 20220
Dear Mr. Keating:
I have received your April 5 request to review the Omnibus
Anti-Drug Abuse Act of 1988 to determine if its provisions
would significantly affect the National Drug Intelligence
-Strategy and Implementation Plan. From an analysis of
S 2205 it would appear that nothing in the proposed bill
would contravene our drug intelligence strategy. Neverthe-
less, the bill is not adequate to our national drug
intelligence needs and could affect the strategy in several
ways.
If the bill is passed and fully funded there will be
additional resources for EPIC ($4 million). In addition,
agencies receiving additional positions may allocate some of
them to their intelligence programs. But, the omnibus bill
fails to authorize directly additional resources for drug
intelligence programs.
Other provisions of the bill, such as the Latin American
Anti-Drug Strike Force and the Southwest Border Task Force
would create a greater demand for drug intelligence
information and services. Neither the law enforcement
agencies nor the Intelligence Community have been authorized
intelligence resources to address these new programs.
Although not bearing on the strategy directly, certain
provisions of the bill would realign strategic intelligence
responsibilities among the drug control agencies. Thus,
transferring from the Department of State to DEA the
responsibilities to determine illicit drug crop acreages
LIM IAL USE
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4
?
1'
-2
under cultivation and to assess the effectiveness of
eradication programs would result in a disruption that may
not be justifiable. It should also be noted that the
increased pressure put on the validity of our strategic
assessments will require greatly improved data collection
and analysis. Here we depend a great deal on the
Intelligence Community, and they have not been earmarked
additional resources in this bill.
Because of the failure of the bill to provide additional
resources for drug intelligence programs, the bill generally
will strain our ability to implement the National Drug
Intelligence Strategy. At this time, the National Drug
Intelligence Committee has no legislative proposals for
inclusion in an omnibus bill.
If I can be of any further assistance, please let me know.
Sincerely
C. Lawn
Ch rman, National Drug
Intelligence Committee
cc: NDIC Members
Mr. David Pickens
LIMITED OFFICIAL USE
Declassified in Part - Sanitized Copy Approved for Release 2012/11/09: CIA-RDP90M00551R001600840026-4